Clinical Trial Update: Androgen-responsive POSLUMA-guided Intra-prostatic Boost [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for androgen-responsive POSLUMA-guided intra-prostatic boost in intermediate- and high-risk prostate cancer, currently not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Martin T. King, MD, PhD | Conditions: Intermediate Risk Prostate Cancer, High Risk Prostate Cancer | Phase 2 | Status: NOT_YET_RECRUITING